Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parasympathetic fibers innervating cranial blood vessels constitute the efferent arm of the trigemino-parasympathetic reflex, primarily originating from the sphenopalatine ganglion (SPG). These fibers provide dense innervation to the dural and cerebral vasculature, where they release potent vasodilatory mediators such as vasoactive intestinal peptide (VIP), acetylcholine, and nitric oxide. In pathological states like migraine and cluster headache, overactivity of these fibers leads to significant cranial vasodilation and plasma protein extravasation, contributing to the severe pain and autonomic symptoms (e.g., lacrimation and rhinorrhea) characteristic of these disorders. Medical intervention typically focuses on desensitizing this pathway through neuromodulation of the SPG, local anesthetic blocks, or pharmacological agents like botulinum toxin that inhibit neurotransmitter release. Recent drug development has also targeted specific receptors for the neuropeptides released by these fibers, such as VIP receptor antagonists, to provide more localized and effective relief for trigeminal autonomic cephalgias.
Therapeutic strategies involve the inhibition of neurotransmitter release (e.g., acetylcholine), the blockade of ganglionic transmission via local anesthetics, or the antagonism of effector neuropeptides like vasoactive intestinal peptide (VIP) to prevent cranial vasodilation and neurogenic inflammation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasympathetic fibers innervating cranial blood vessels.